Step 1 of 3
Ozempic / Wegovy
Pure GLP-1 agonist. Well-studied, predictable, FDA-approved.
GLP-1 only: satiety and insulin sensitivity
Mounjaro / Zepbound
Dual GLP-1/GIP agonist. More effective than semaglutide.
GLP-1 + GIP: deeper metabolic rebalancing with improved nutrient partitioning
Research compound
Triple agonist (GLP-1/ GIP/ Glucagon). Most powerful, research phase.
GLP-1 + GIP + Glucagon: whole-system metabolic rewiring with enhanced fat oxidation
